BKGI logo

Bangkok Genomics Innovation SET:BKGI Stock Report

Last Price

฿2.00

Market Cap

฿1.2b

7D

-3.8%

1Y

n/a

Updated

18 Mar, 2025

Data

Company Financials +

Bangkok Genomics Innovation Public Company Limited

SET:BKGI Stock Report

Market Cap: ฿1.2b

BKGI Stock Overview

Provides medical analysis services in Thailand. More details

BKGI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends1/6

Rewards

Trading at 60.6% below our estimate of its fair value

Earnings are forecast to grow 20.17% per year

Earnings grew by 56.1% over the past year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (THB1B)

Volatile share price over the past 3 months compared to the TH market


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Bangkok Genomics Innovation Public Company Limited Competitors

Genesis Fertility Center

SET:GFC

฿1.1b

Dental Corporation

SET:D

฿766.5m

Safe Fertility Group

SET:SAFE

฿2.8b

Inspire IVF

SET:IVF

฿497.2m

Price History & Performance

Summary of share price highs, lows and changes for Bangkok Genomics Innovation
Historical stock prices
Current Share Price฿2.00
52 Week High฿5.65
52 Week Low฿1.67
Beta0
1 Month Change-8.26%
3 Month Change-0.99%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-54.55%

Recent News & Updates

Recent updates

Shareholder Returns

BKGITH HealthcareTH Market
7D-3.8%1.5%-0.6%
1Yn/a-25.6%-16.9%

Return vs Industry: Insufficient data to determine how BKGI performed against the TH Healthcare industry.

Return vs Market: Insufficient data to determine how BKGI performed against the TH Market.

Price Volatility

Is BKGI's price volatile compared to industry and market?
BKGI volatility
BKGI Average Weekly Movement9.6%
Healthcare Industry Average Movement4.8%
Market Average Movement5.2%
10% most volatile stocks in TH Market10.3%
10% least volatile stocks in TH Market2.3%

Stable Share Price: BKGI's share price has been volatile over the past 3 months compared to the TH market.

Volatility Over Time: BKGI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TH stocks.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/awww.bangkokgenomics.com

Bangkok Genomics Innovation Public Company Limited provides medical analysis services in Thailand. The company offers screening for fetal chromosomal abnormalities using non-invasive prenatal testing under the NIFTY brand; preimplantation chromosomal abnormality and thalassemia carrier gene screening; infectious disease group analysis; testing for human papilloma virus; and monkeypox virus, COVID-19 Pathogen, and COVID-19 pathogen immunity testing. It also provides other screening tests, such as cancer-related gene screening to predict the risk of inherited cancer, to monitor treatment and select drugs that are appropriate for one's genetics, and to provide treatment and disease prevention.

Bangkok Genomics Innovation Public Company Limited Fundamentals Summary

How do Bangkok Genomics Innovation's earnings and revenue compare to its market cap?
BKGI fundamental statistics
Market cap฿1.20b
Earnings (TTM)฿50.17m
Revenue (TTM)฿337.59m

23.9x

P/E Ratio

3.6x

P/S Ratio

Is BKGI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BKGI income statement (TTM)
Revenue฿337.59m
Cost of Revenue฿197.52m
Gross Profit฿140.08m
Other Expenses฿89.91m
Earnings฿50.17m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.084
Gross Margin41.49%
Net Profit Margin14.86%
Debt/Equity Ratio0%

How did BKGI perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

57%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/18 11:59
End of Day Share Price 2025/03/18 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bangkok Genomics Innovation Public Company Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mintra RattayapasKrungsri Securities Public Company Limited